Lean Mass and GLP-1: How Not to Lose Muscle While Losing Fat

Losing weight is not the same as losing fat. It is one of the uncomfortable truths that the scientific literature has been quantifying with each DEXA substudy of the large trials of semaglutide and tirzepatide. The weight loss measured on the scale includes water, fat, connective tissue and — the part that is important to preserve — skeletal muscle.

Between 26% and 40% of the weight lost with GLP-1 in recent trials corresponds to lean mass. That does not mean that these peptides are bad or that they should not be used. It means that how the treatment is accompanied determines what type of loss is obtained: one that is mostly fat with good muscle preservation, or one where more muscle than necessary is lost.

In this guide we review what the evidence says about body composition in GLP-1 and, above all, the three actionable pillars that the literature recommends to preserve lean mass during treatment.

The Inconvenient Data: What the DEXA Substudies Say

Neeland I.J. and collaborators published in2024 (volume 26, supplement 4, pages 16–27) a specific review on body composition in modern GLP-1 assays. The figure that summarizes the problem: between 26% and 40% of the weight lost in these trials corresponds to lean mass ().

This figure is not exclusive to GLP-1. Any sustained caloric deficit produces loss of lean mass. What changes with GLP-1 is the absolute magnitude of the weight loss, which in absolute terms also amplifies the loss of lean mass. If you lose 15% of your body weight, losing 30-40% of that as lean mass is a substantial amount.

Specific data from large trials confirm the pattern:

Wilding J.P.H. and collaborators published in 2021 (volume 384, pages 989–1002) the results of STEP 1 with DEXA analysis. Patients lost 15% of their body weight on average: 19.3% of fat mass and 9.7% of absolute lean mass. The good news: Lean mass ratio (lean mass divided by total weight) increased 3 percentage points, indicating that body composition improved even though absolute lean mass fell.

Look M., Dunn J.P., Kushner R.F. and collaborators published in2025 (volume 27, number 5) the DEXA substudy of SURMOUNT-1. The patients lost 21.3% of their body weight: 33.9% of fat mass and 10.9% of absolute lean mass. The estimated difference between treatment and placebo for lean mass was −8.3% (95% CI −10.6 to −6.1; p<0.001).

In both trials, the majority of the weight lost was fat. But the absolute amount of lean mass lost is significant enough to merit specific mitigation strategies.

Why Does Lean Mass Really Matter?

Skeletal muscle is not just aesthetics. It fulfills central biological functions that determine functional capacity, metabolic health and physiological reserve:

Muscle is metabolically active. Each kilo of lean mass contributes to energy expenditure at rest. Losing muscle means lowering basal expenditure, which can facilitate weight recovery if treatment is suspended.

Muscle is the body's main glucose sink. More active muscle mass means better management of the carbohydrates consumed and lower risk of long-term insulin resistance.

Strength, postural balance, the ability to lift objects, climb stairs, and maintain functional independence depend on adequate muscle mass. This becomes critical after age 50.

In catabolic episodes (acute illness, hospitalization, surgery), the body mobilizes muscle mass to sustain vital functions. Whoever enters these episodes with low muscle reserve has a worse prognosis.

Prado C.M., Phillips S.M., Gonzalez M.C., Heymásfield S.B. published in2024 (Volume 12, Issue 11, Pages 785–787) a direct commentary on this concern. Its central argument: accelerated muscle loss with GLP-1 — especially in people over 50 years of age — increases the risk of sarcopenia and functional frailty. They explicitly recommended monitoring of body composition and resistance training during treatment.

There is an important additional fact: That is, someone who finishes a treatment cycle with less lean mass and then regains weight ends up with a worse body composition than the initial one. That is why preserving muscle during treatment is strategic, not optional.

Pilar 1: Proteína Suficiente

Adequate protein nutrition is the foundation of any strategy to preserve lean mass during a caloric deficit. Without enough protein, no training can compensate.

¿Cuánta protein?

Clinical nutrition guidelines for muscle preservation in adults during caloric deficit — including PROT-AGE recommendations and reviews by Phillips S.M. in the context of sarcopenia — they suggest This is significantly above the general recommendations for the sedentary population (0.8 g/kg/day) because caloric deficit increases the relative demand for protein.

Algunas consideraciones prácticas:

• Use target body weight:
• Spread over 3–4 meals:
• Include protein in breakfast:

Quality protein sources

• Carnes magras (pollo, res magra, pescado).
• Huevos.
• Lácteos (yogur griego, queso cottage, leche).
• Protein powder (whey, casein, complete vegetable mixes).
• Combinations of legumes with cereals (beans with rice, lentils with quinoa) for predominantly plant-based diets.

When appetite is suppressed

A common challenge with GLP-1 is that rapid satiety makes it difficult to reach the daily protein quota. Some practical strategies:

• Start meals with protein ("protein first" rule).
• Use protein shakes when solid food is difficult.
• Eat smaller, more frequent meals instead of three large meals.
• Prefer foods with high protein density by volume.

Pillar 2: Strength Training

If protein is the building material, resistance training is the signal that tells the body that that material should be used to build muscle, not burn. Without mechanical stimulation, the body in caloric deficit tends to sacrifice lean mass.

Frecuencia recomendada

Systematic reviews on sarcopenia and muscle preservation during weight loss converge on a recommendation: More frequent sessions do not provide additional benefit for preservation; Less frequent may not be enough stimulation.

Training type

The most effective stimulus is resistance training with loads: free weights, machines, resistance bands or calisthenics with progression of difficulty. The important thing is:

• Enough load so that the last 2–3 repetitions of each set are genuinely difficult (high perceived effort).
• Compound movements that involve multiple muscle groups (squats, deadlifts, presses, rows, pull-ups).
• Weekly progression. The body adapts — if the load does not increase gradually, the stimulation loses effectiveness (progressive overload).

El cardio no reemplaza

Walking is excellent for general cardiovascular health, but it does not preserve lean mass in caloric deficit. People who replace resistance training with cardio end up losing more muscle. Cardio can coexist with resistance training, but it does not replace it.

For those starting from scratch:

Pillar 3: Body Composition Monitoring

The scale is an insufficient tool to evaluate real progress during GLP-1 treatment. Two people can lose the same 10 kilos: one losing mainly fat, another losing proportionally more muscle. The scale does not distinguish. The tools that do:

→ DEXA (Dual-energy X-ray Absorptiometry)

The gold standard for measuring body composition. Distinguishes fat mass, lean mass and bone mass accurately. Available in many medical imaging centers and some specialized gyms in Colombia. Moderate cost, one session is sufficient every 3–6 months.

→ BIA (Bioimpedancia)

More accessible and economical, although less accurate than DEXA. Useful for monitoring trends over time, especially if it is always done under similar conditions (hydration, time of day, fasting).

→ Mediciones antropométricas

Waist, hip, arm and thigh perimeters, complemented by scale. The most accessible and profitable. Changes in perimeter (especially that of the thigh at mid-height) are a useful indicator of muscular changes.

What is not measured is not managed. It is the practical principle that matters most in body composition. It is recommended to measure body composition every 3–6 months during treatment.

Special Considerations for Older Adults

Prado C.M.'s comment and collaborators in2024 placed special emphasis on those over 60 years of age. The biological reason: sarcopenia (age-related muscle loss) is already underway after that age, and any caloric deficit accelerates it. Muscle reserve is lower to begin with and the consequences of losing more are greater.

For older adults using GLP-1, the literature suggests:

• Aim for the upper end of the protein range (closer to 2.0 g/kg/day than 1.4).
• Prioritize resistance training even over cardio. Muscle function is the most modifiable factor of functional longevity at this age.
• Closer monitoring of body composition (every 3 months).
• Most conservative weight loss rate. Losing faster increases the proportion of lean mass in total loss.
• Periodic functional evaluation (squat, grip, walking speed) as a complement.

Context: No Reason Not to Use LPG-1

Lean mass loss occurs in any sustained caloric deficit, including traditional calorie-restricted diets, prolonged intermittent fasting, and bariatric surgery (where the proportion of lean mass lost may be similar or greater).

The problem is not unique to GLP-1 — it is inherent to the physiological process of losing weight. GLP-1 facilitates this process with unprecedented success, but the biological principle is the same. The question, then, is not whether or not to use GLP-1, but how to use them well.

The three pillars — sufficient protein, resistance training, monitoring body composition — are the practical answer. Applied consistently, they transform the treatment experience: instead of "I lost 15 kilos, I don't know how much was muscle," the result is "I lost 15 kilos and maintained my functional capacity and my lean mass."

Conclusion: Weight Loss Done Right

GLP-1 are a powerful tool for weight loss. But like any powerful tool, its optimal use depends on how it is accompanied. The difference between losing weight and losing weight well lies in three specific actions: eating enough protein, training strength regularly, and measuring body composition periodically.

This isn't complicated in theory, but it requires intention. The good news is that the compounding effects are substantial. A person who combines GLP-1 with these three pillars not only loses more relative fat than someone who does not; It also ends the treatment with better function, better basal metabolism, better insulin sensitivity and better physiological reserve in the face of aging.

The new era of GLP-1 is not about losing weight at any cost. It's about transforming body composition in a sustainable way. And that requires more than just a peptide — it requires a comprehensive rebody composition strategy.

Encuentra más information aquí:

Referencias Clave

1. Neeland I.J. et al. Body composition changes with GLP-1 receptor agonists: implications for muscle preservation. Diabetes Obesity & Metabolism 2024;26(Suppl 4):16–27. [Link]
2. Wilding J.P.H. et al. . New England Journal of Medicine 2021;384:989–1002.
3. Look M., Dunn J.P., Kushner R.F. et al. Body composition changes with tirzepatide in SURMOUNT-1: a DXA substudy. Diabetes Obesity & Metabolism 2025;27(5).
4. Prado C.M., Phillips S.M., Gonzalez M.C., Heymásfield S.B. Muscle matters: the effects of medically induced weight loss on skeletal muscle. The Lancet Diabetes & Endocrinology 2024;12(11):785–787. [Link]
5. Bauer J., Biolo G., Cederholm T. et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. JAMDA 2013;14(8):542-559. [Link]
6. Phillips S.M., Chevalier S., Leidy H.J. Protein "requirements" beyond the RDA: implications for optimizing health. Applied Physiology Nutrition and Metabolism 2016;41(5):565-572. [Link]